OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 32.45
-0.15 (-0.46%)
Sep 24, 2026, 1:30 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 4.27 billion as of September 25, 2026. Its market cap has decreased by -37.43% in one year.
Market Cap
4.27B
Enterprise Value
4.93B
Revenue
52.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.45
ChartMarket Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 4.27B, a decrease of -74.69%. That is a compound annual growth rate of -9.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 4.27B | -39.86% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 5.26B |
| UnicoCell Biomed | 4.64B |
| Mycenax Biotech | 4.63B |
| Sinew Pharma | 4.28B |
| BRIM Biotechnology | 4.14B |
| Pharmosa Biopharm | 4.11B |
| Formosa Pharmaceuticals | 3.85B |
| Great Novel Therapeutics Biotech & Medicals | 3.75B |